Blog

Novartis NVS announced that the FDA approved a label expansion of psoriasis drug Cosentyx.

The regulatory body approved the drug for treating pediatric patients 12 years and older with moderate to

Over the past couple of years, the integration of Artificial Intelligence (AI) has ignited a revolutionary shift within the biotechnology industry. By mining massive biological datasets, AI has been

Shares of Oil-Dri Corporation of America ODC have declined 1.7% since reporting results for the second quarter of fiscal 2026. This compares with the S&P 500 index’s 2.1% fall over the same time

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core

Beyond diagnostics and data licensing, Tempus AI TEM is also focused on monetizing clinical applications and healthcare software designed for healthcare providers. The company is developing several

The Goldman Sachs Group, Inc. GS is making a more decisive strategic pivot, with private credit emerging as a key pillar of its long-term growth story. The company is aggressively expanding its

Belden (BDC) has been on a downward spiral lately with significant selling pressure. After declining 23.5% over the past four weeks, the stock looks well positioned for a trend reversal as it is now

Ford Motor Company (F) has been beaten down lately with too much selling pressure. While the stock has lost 17.4% over the past four weeks, there is light at the end of the tunnel as it is now in

A downtrend has been apparent in Nu Holdings Ltd. (NU) lately with too much selling pressure. The stock has declined 17.4% over the past four weeks. However, given the fact that it is now in

Orthofix (OFIX) has been beaten down lately with too much selling pressure. While the stock has lost 12.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

Goldman Sachs (GS) has been beaten down lately with too much selling pressure. While the stock has lost 13.6% over the past four weeks, there is light at the end of the tunnel as it is now in

U.S. Bancorp USB has been building a steadier growth profile as loan pipelines strengthen and funding costs stabilizes. That combination is showing up in net interest income (NII) and fee-driven

The Home Depot, Inc. HD is expanding its digital and logistics capabilities with the planned launch of a real-time delivery tracker for large and bulky building materials. The feature, expected to

Everpure, Inc. PSTG and Hewlett Packard Enterprise Company HPE are two prominent players in the enterprise storage market, though they approach the industry from different strategic positions

Target Corporation TGT continues to strengthen its omnichannel capabilities as same-day services gain traction with consumers seeking speed and convenience. The retailer reported that same-day

Investors in Universal Corporation UVV need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2026 $30 Call had some of the highest implied

For Immediate Release

Chicago, IL – March 16, 2026 – Today, Zacks Equity Research discusses Terns Pharmaceuticals TERN, ADMA Biologics ADMA, ANI Pharmaceuticals ANIP and Liquidia Corp. LQDA.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium